Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
62,831.56 -1,594.11 (-2.47%) CMC Crypto 200
1,306.07 -90.47 (-6.48%)
Singular Genomics Systems, Inc. (OMIC)
After hours:
| Previous close | 0.4006 |
| Open | 0.4100 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.3763 - 0.4100 |
| 52-week range | 0.3100 - 1.2100 |
| Volume | |
| Avg. volume | 114,390 |
| Market cap | 29.938M |
| Beta (5Y monthly) | 1.40 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.3000 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 0.85 |
Insider MonkeySingular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2023 Earnings Call Transcript
Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2023 Earnings Call Transcript March 18, 2024 Singular Genomics Systems, Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were $-0.34. OMIC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone, and […]
- Thomson Reuters StreetEvents
Q4 2023 Singular Genomics Systems Inc Earnings Call
Q4 2023 Singular Genomics Systems Inc Earnings Call
GlobeNewswireSingular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
SAN DIEGO, March 18, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended December 31, 2023. “We ended 2023 on a strong note, shipping our largest number of quarterly instruments to-date,” said Drew Spaventa, Chairman and C
